Can AI Replace Life Sciences PR? What It Can Do & Where Human Expertise Still Matters
Table of contents
Can AI Replace Life Sciences PR? What It Can Do & Where Human Expertise Still Matters
By Joe Morgan, Media Relations Manager, Sōvyn
AI can outline a press release, suggest media angles and draft a pitch in seconds. For life sciences, biotech and health tech companies looking to get their message out quickly, that can be appealing.
But here’s the thing: speed doesn’t build relationships. In PR, building and maintaining meaningful relationships will always be more valuable than simply delivering content quickly.
This is especially true in life sciences and healthcare, where the subject matter is complex and credibility matters. In life sciences and healthcare PR, human expertise isn’t just nice to have. It’s essential.
AI Can Help With PR Work. It Can’t Replace the Thinking
AI can help research a topic, spot emerging conversations in healthcare and life sciences, organize background information, brainstorm ideas and give a first draft a running start. Those are useful capabilities. They save time and give PR professionals more room for the work that requires experience and judgment. The problem starts when efficiency becomes the goal instead of a way to get a better result.
Just because AI can draft a press release quickly doesn’t mean the release is newsworthy or compelling. AI might generate 10 potential media angles in seconds, but that doesn’t mean any of them are relevant to the healthcare and biotech reporters on your list. An article written by ChatGPT might sound authoritative, but if the facts and context aren’t accurate, it destroys your credibility instantly.
Media relations teams spend their careers learning how target audiences behave and what their pain points are. They learn what makes a story newsworthy, fact-check statements and build human relationships with reporters. AI’s speed can’t compete with a PR professional’s expertise and intuition.
In Life Sciences & Biotech, Getting the Story Right Matters
A company might be developing a new therapy, introducing a medical device or bringing an AI-powered health tech platform to market. In each case, communicating the details takes more than turning technical information into simpler language.
Life sciences and biotech PR professionals need to understand what the science actually says, what the evidence supports and why a particular development matters. They also need to recognize the difference between a promising finding and a proven outcome.
AI can summarize research and help translate complex material into accessible language. But it can miss important context, overstate a conclusion or make a claim sound more definitive than the evidence allows. A confident-sounding sentence isn’t necessarily an accurate one.
That’s why human involvement and oversight matter, particularly when biotech and healthcare communications involve clinical findings, patient outcomes, product capabilities or emerging technologies.
A PR professional who understands the subject matter can ask the questions an AI-generated draft might miss:
- Does the evidence support this claim?
- Is important context missing?
- Does the pitch explain what this development means for the industry, or does it simply repeat what the company wants people to know?
Those questions protect credibility. And in life sciences, credibility is everything.
The Hardest Part of Healthcare PR Is Often Finding the Story
One of the biggest misconceptions about PR is that the job is mostly writing and distributing press releases. It’s not.
Healthcare, health tech and life sciences companies have plenty of news they want to share: product launches, partnerships, research milestones, new hires and business updates. But not every announcement is a story a reporter needs or even wants to cover.
The challenge is figuring out what makes a development relevant beyond the company itself.
A new health tech solution, for example, might be more interesting as part of a larger conversation about patient safety, clinical workflows or the challenges healthcare organizations face. The product is part of the story, but the problem it helps solve is what makes the story worth telling.
AI can suggest those connections. An experienced healthcare PR professional has to judge whether they hold up, whether the timing makes sense and whether the angle offers something genuinely useful to a reporter and their audience.
Sometimes that means pushing back on a client’s original idea. Sometimes it means waiting for a better news hook. And sometimes it means recognizing that an announcement isn’t ready for a media pitch at all.
That judgment is hard to automate because it depends on context, experience and an understanding of what does and doesn’t make news.
You Can’t Automate Trust With Healthcare & Life Sciences Journalists
Media relationships are another part of PR that AI can’t simply take over.
Reporters covering healthcare, biotech and life sciences receive a steady stream of pitches. They don’t need more emails that summarize a company’s latest announcement and explain why it’s supposedly groundbreaking. They need relevant stories, credible sources and people who understand what they’re reporting on.
Building those relationships takes time. It means knowing what a reporter covers, paying attention to the stories they’re working on and reaching out when there’s a real connection between their interests and the expertise a client can offer.
It also means respecting their time. A thoughtful, well-targeted pitch is more valuable than dozens of generic emails sent at scale.
Trust comes from consistently bringing reporters something useful, being responsive when they have questions and connecting them with executives, clinicians and scientists who can speak knowledgeably about the subject. Those relationships are built through human interaction and follow-through, not better prompts.
When the Stakes Are High in Life Sciences Communications, Judgment Matters Even More
The limits of AI become especially important when a company is handling a sensitive announcement, a difficult media inquiry or a situation that could affect its reputation.
In life sciences and biotech, communications may involve clinical setbacks, product safety questions, regulatory developments or new evidence that changes how a company can talk about its work. These situations require careful thought about what is known, what is still uncertain and how different audiences may interpret the information.
AI can help organize facts, prepare draft responses and explore potential questions. But it shouldn’t make the final call on what a company says or how it responds.
That responsibility requires people who can weigh the evidence, consult the right experts, recognize potential risks and understand the consequences of getting the message wrong.
The same principle applies to everyday healthcare communications. AI-generated content needs to be checked. Claims need to be verified. And messages need to reflect what a company can responsibly say, not just what sounds persuasive.
The Future of Life Sciences & Healthcare PR Isn’t AI or Humans. It’s Both.
AI is going to stay part of the communications landscape, and PR teams should learn how to use it well. Ignoring the technology isn’t the answer, but neither is treating every AI-generated draft as ready to publish.
The opportunity for life sciences, biotech and health tech organizations is to use AI for what it does well while keeping human expertise at the center of the work.
Let AI help with research, early drafts and repetitive tasks. Let experienced PR professionals decide what makes a story newsworthy, challenge weak messaging, build relationships with journalists and make sure the science is communicated accurately.
The goal of PR isn’t simply to produce content quickly. It’s to earn media attention, build credibility and thought leadership, and help the right audiences understand why a company’s work matters.
AI can make parts of that process faster. It can’t guarantee that a reporter will care about the story, that a message will resonate or that an audience will trust what it hears.
Those outcomes depend on strategy, relationships and judgment.
Joe Morgan is an experienced leader in media relations, PR strategy, and content creation with a strong foundation in journalism. He brings deep expertise in securing earned media coverage that elevates thought leadership, builds trust, and drives meaningful awareness. With a passion for storytelling and a proven ability to shape narratives that resonate, Joe is a natural fit for our mission to help healthcare, health tech, biotech, and life sciences organizations communicate with clarity, impact, and purpose.
Search
Less Scrolling.
More Knowing.
Subscribe to our newsletter for quick snippets of news & trends in health, life sciences, and tech marketing & PR.
